845890-35-9 Usage
Uses
Used in Agricultural Applications:
Acetic acid, [(5-bromo-2-pyridinyl)oxy]-, methyl ester is used as a pesticide and herbicide for controlling various types of weeds and pests. It is applied as a foliar spray or soil treatment to target specific plants and insects, enhancing crop protection and yield.
Used in Horticultural Applications:
In horticulture, Acetic acid, [(5-bromo-2-pyridinyl)oxy]-, methyl ester is utilized as a pesticide and herbicide to manage unwanted plant growth and insect infestations. Its application helps maintain the health and aesthetic appeal of gardens and landscapes.
It is crucial to handle Acetic acid, [(5-bromo-2-pyridinyl)oxy]-, methyl ester with care due to its potential toxicity to humans and non-target organisms if not used properly. Proper application methods and safety precautions are essential to ensure its effectiveness and minimize risks.
Check Digit Verification of cas no
The CAS Registry Mumber 845890-35-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,5,8,9 and 0 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 845890-35:
(8*8)+(7*4)+(6*5)+(5*8)+(4*9)+(3*0)+(2*3)+(1*5)=209
209 % 10 = 9
So 845890-35-9 is a valid CAS Registry Number.
845890-35-9Relevant academic research and scientific papers
PYRROLO [2, 3-B] PYRIDINES OR PYRROLO [2, 3-B] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF
-
Paragraph 0401; 0934-0936; 0958-0960, (2020/01/08)
Disclosed herein is a compound of Formula (AIII) or (III), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of treating HPK1 related disorders or diseases by using the compound disclosed herein.
2-SUBSTITUTED BENZOIC ACID DERIVATIVES AS HM74A RECEPTOR AGONISTS
-
Page/Page column 43-44, (2010/02/10)
Therapeutically active anthranilic acid derivatives of Formula (I) wherein R1, R2 and Z are as defined in the specification, processes for the preparation of said derivatives, pharmaceutical formulations containing the active compounds and the use of the compounds in therapy, particularly in the treatment of diseases in which under-activation of the HM74A receptor contributes to the disease or in which activation of the receptor will be beneficial, are disclosed.
